
Keywords: ID; intradermal; SC; subcutaneous; HA; hemagglutinin; HAI; hemagglutination inhibition; NT; microneutralization; GMT; geometrical mean titer; GMTR; GMT ratio; SCR; seroconversion ratio; SPR; seroprotection ratio; AE; adverse event; CHMP; The Committee for